Morgan Stanley lowered the firm’s price target on Aramark (ARMK) to $43 from $44 and keeps an Equal Weight rating on the shares. Organic growth of 13.8% missed estimates by about 200 basis points, while 2026 guidance was roughly in line with expectations, the analyst tells investors in a post-earnings note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARMK:
- Aramark price target lowered to $46 from $47 at Baird
- ARAMARK Holdings: Hold Rating Maintained Amid Mixed Financial Performance and Deferred Revenue
- Aramark Reports Strong Fiscal 2025 Earnings Growth
- Aramark’s Earnings Call Highlights Growth Amid Challenges
- ARAMARK Holdings: Strong Business Momentum and Robust Pipeline Justify Buy Rating